US 10829550
Polynucleotides encoding anti-CXCL13 antibodies
granted A61KA61K2039/505A61P
Quick answer
US patent 10829550 (Polynucleotides encoding anti-CXCL13 antibodies) held by VACCINEX, INC. expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/04, A61P13/08